The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
SEATTLE Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United States Patent ...
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leader in accessible and scalable single cell sequencing solutions, today announced a significant expansion of its Evercodeâ„¢ WT Mega Kit functionality.
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier provider of Next ...
(BUSINESS WIRE )--Parse Biosciences , a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board (PTAB) of the United ...
SEATTLE, December 19, 2024--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, is pleased to announce that Admera Health, a premier ...
SEATTLE, February 04, 2025--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the Patent Trial and Appeal Board ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results